References
- Jones R, Lyderard S E. Prevalence of symptoms of dyspepsia in the community. Lancet 1989; 1: 47–51
- Jones R, Lyderard S E, Hobbs F DR, Kenkre J E, Williams E I, Jones S J. Dyspepsia in England and Scotland. Gut 1990; 31: 401–5
- Tibblin G. Introduction to the epidemiology of dyspepsia. Scand J Gastroenterol 1985; 20(Suppl 109)29–33
- Nyren O, Adami H O, Gustafsson S, Lööf L, Nyberg A. Social and economic effects of non ulcer dyspepsia. Scand J Gastroenterol 1985; 20(Suppl 109)41–5
- van Veldhuyser Zanter, Tyfgat K MAJ, Jalak S, Goodacre R L, Hunt R H. Can gastritis symptoms be evaluated in clinical trials? An overview of treatments of gastritis, non ulcer dyspepsia and campylobacter-associated gastritis. Clin Gastroenterol 1989; 11: 496–50
- Lööf L, Adami H O, Agenas T, Gustafsson S, Nyberg A, Nyren O. The diagnosis and therapy survey October 1978-March 1983, health care consumption and current drug therapy in Sweden with respect to the clinical diagnosis of gastritis. Scand J Gastroenterol 1985; 20(Suppl 109)35–9
- Thors H, Sigurdsson H, Oddsson E, Thjodleifsson B. Könnun á notkun magalyfja (A02B) meõal Íslendinga [abstract]. Læk-nablaõiõ (Icelandic Med J) 1992; 78(Suppl 21)59
- La Broody S, Lowell D, Misiewicz J. The treatment of non ulcer dyspepsia. Cimetidine: The Westminster Hospital Symposium, C Wasfell, P Lance. Churchill Livingstone, London 1978; 131–40
- Lance P. Cimetidine for non ulcer dyspepsia [abstract]. Gastroenterology 1981; 80: 1203
- Bendtsen F, Danö P, Guldhammer B, Remvtg L, Krogsöe O. Cimetidinebehandling af röntgennegative dyspepsi. Ugeskr Laeger 1983; 145: 3090–3
- Kelbak H, Linde J, Eriksen J, Munkgaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281–7
- Gottard. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18
- Delattre M, Malesky M, Prinzie A. Symptomatic treatment of non ulcer dyspepsia with cimetidine. Curr Ther Res 1985; 37: 980–991
- Talley N J, McNeil D, Hayden A, Piper W. Randomized double-blind, placebo-controlled crossover trial of cimetidine and pir-enzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149–56
- Saunders J BH, Oliver R J, Higson D L. Dyspepsia incidence of non ulcer disease in a controlled trial of ranitidine in general practice. Br Med J 1986; 292: 665–8
- Nyren O, Adami H O, Bates S, Bergström R, Gustavsson S, Lööf L. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43
- Kairakuoma M I, Hentile R, Alavaikko M, Kellosalo J, Stahlberg M, Jalovaara P. Sucralfate versus placebo in treatment of non-ulcer dyspepsia. Am J Med 1987; 83(Suppl 3B)51–5
- McCarthy D M. Drug therapy. Sucralfate. N Engl J Med 1991; 325: 1017–25
- Young M J, Bresnitz E A, Strom B L. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med 1983; 99: 248–51
- Sonnenberg A. Geographical and temporal variations in the occurrence of peptic ulcer disease. Scand J Gastroenterol 1985; 2(Suppl 110)11–24
- Bonnevie O. Future research, methodological aspects. Scand J Gastroenterol 1987; 22(Suppl 128)114–6
- Oddsson E, Binder V, Thorgeirsson T, Jonasson T A, Gunnlaugsson O, Wulff M. A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer and X-ray negative dyspepsia. Scand J Gastroenterol 1978; 13: 489–95
- Kristinsson K G, Thjodleifsson B, Sigvaldadóttir E, Jensson Ó, Wadström T. Mslingar á mótefnum gegn Helicobacter pylori í Íslendingum. Læknablaøiô (Icelandic Med J) 1992; 78(Suppl 21)60
- Tytgat G NJ. Clinical efficacy of sucralfate in reflux oesophagitis. Comparison with cimetidine. Am J Med 1987; 83(Suppl 3B)38–42
- Williams R M, Orlando R C, Bozynski E N. Multicenter trial of sucralfate suspension for the treatment of reflux oesophagitis. Am J Med 1987; 83(Suppl 3B)61–6